Dualsystems Biotech None

Dualsystems Biotech is a Swiss biotech company established in 2000 that provides custom proteomics services for industry and academia. They specialize in elucidating protein-protein interaction in living cells, focusing on the cell membrane. The company successfully introduced yeast 2-hybrid technologies to the market and has been the leader in broadening its fields of application. In recent years, mass spectrometry-based proteomics technologies have become a major pillar of the company's expertise. They now exclusively focus on their mass spectrometry-based CaptiVate and CaptiRec technologies. Dualsystems Biotech has built a solid investor base through two financing rounds in 2000 and 2007 to support their technology-driven growth strategy.